We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

14 hedge funds and large institutions have $8.73M invested in Alimera Sciences in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

3% less capital invested

Capital invested by funds: $9M → $8.73M (-$276K)

30% less funds holding

Funds holding: 20 → 14 (-6)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
14
Holders Change
-6
Holders Change %
-30%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
5
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$647K
2
VCIM
Velan Capital Investment Management
Georgia
+$247K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$73K
4
TRCT
Tower Research Capital (TRC)
New York
+$5.03K
5
Wells Fargo
Wells Fargo
California
+$43

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$153K
2
Renaissance Technologies
Renaissance Technologies
New York
-$91.3K
3
BlackRock
BlackRock
New York
-$79.9K
4
Citadel Advisors
Citadel Advisors
Florida
-$79K
5
PCM
Perritt Capital Management
Illinois
-$57.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$3.4M +$647K +106,222 +19%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.27M – – –
VCIM
3
Velan Capital Investment Management
Georgia
$1.16M +$247K +40,601 +22%
PAI
4
Palo Alto Investors
California
$1.02M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$755K -$4.83K -793 -0.5%
Renaissance Technologies
6
Renaissance Technologies
New York
$572K -$91.3K -14,999 -12%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$194K +$73K +12,002 +46%
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$98K – – –
BCM
9
Bridgeway Capital Management
Texas
$93K – – –
PCM
10
Perritt Capital Management
Illinois
$91K -$57.2K -9,400 -34%
BlackRock
11
BlackRock
New York
$65K -$79.9K -13,128 -50%
TRCT
12
Tower Research Capital (TRC)
New York
$10K +$5.03K +826 +71%
Deutsche Bank
13
Deutsche Bank
Germany
– -$153K -28,052 Closed
Citadel Advisors
14
Citadel Advisors
Florida
– -$79K -14,402 Closed
OIA
15
Optimum Investment Advisors
Illinois
– -$22K -4,108 Closed
JP Morgan Chase
16
JP Morgan Chase
New York
– -$12K -2,198 Closed
AA
17
Ancora Advisors
Ohio
– -$2K -333 Closed
Wells Fargo
18
Wells Fargo
California
– +$43 +7 +23%

ALIM Hedge Fund Activity: Q3 2022 in Review

14 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2022, worth a combined $8.73M — down 3.1% from $9M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ALIM and 0 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 5 added.

The largest buyer was Morgan Stanley, adding an estimated $647K. The largest seller was Deutsche Bank, exiting entirely with an estimated $153K sold.

  • 14 institutional investors held Alimera Sciences (ALIM) as of Q3 2022, down from 20 in Q2 2022.
  • Funds reported $8.73M of Alimera Sciences stock for Q3 2022, down 3.1% quarter-over-quarter.
  • 0 funds opened new Alimera Sciences positions in Q3 2022 and 6 closed out, a net change of -6 holders.
  • The largest Alimera Sciences buyer in Q3 2022 was Morgan Stanley, an estimated $647K added.
  • The largest Alimera Sciences seller in Q3 2022 was Deutsche Bank, an estimated $153K sold.

Based on aggregated 13F filings for Q3 2022.